# K093592: Advocate Redi-Cod Duo Blood Glucose Plus Blood Pressure Monitoring System, Model TD-3223

- Pathway: 510(k) (Special)
- Applicant: Taidoc Technology Corporation
- Decided: Feb 25, 2010 after 98 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K070641 (2007). 1 ancestor in all.
No later device cites it as a predicate yet.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K070641: Advocate Duo Blood Glucose Plus Blood Pressure Monitoring System, Model TD-3223, Taidoc Technology Corporation (2007) Summary page 2.

## Indications for use
ADVOCATE Redi-Code Duo Blood Glucose plus Blood Pressure Monitoring System, model no. TD-3223E is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and from the following alternative sites: the palm, forearm, upper-arm, calf and thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. The alternative site testing in the system can be used only during steady-state blood glucose conditions. The system is also intended to measure non-invasively the systolic and diastolic blood pressure and pulse rate. The blood pressure is measured by using a technique in which an inflatable cuff is wrapped around the wrist. The cuff circumference is limited to 5.25' to 7.75". The device is not to be used for the diagnosis or screening of diabetes, hypertension or for testing on neonates. This monitor contains some speaking functions but is not intended for use by the visually impaired.

Source page: https://510kreport.com/device/K093592
Methodology: https://510kreport.com/methodology